DE69903961D1 - Muscarinagonisten und antagonisten - Google Patents

Muscarinagonisten und antagonisten

Info

Publication number
DE69903961D1
DE69903961D1 DE69903961T DE69903961T DE69903961D1 DE 69903961 D1 DE69903961 D1 DE 69903961D1 DE 69903961 T DE69903961 T DE 69903961T DE 69903961 T DE69903961 T DE 69903961T DE 69903961 D1 DE69903961 D1 DE 69903961D1
Authority
DE
Germany
Prior art keywords
muscarinagonists
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69903961T
Other languages
English (en)
Other versions
DE69903961T2 (de
Inventor
Gurmit Grewal
Anna Toy-Palmer
Xiong Cai
Mark Latham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of DE69903961D1 publication Critical patent/DE69903961D1/de
Application granted granted Critical
Publication of DE69903961T2 publication Critical patent/DE69903961T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE69903961T 1998-08-18 1999-08-16 Muscarinagonisten und antagonisten Expired - Fee Related DE69903961T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (2)

Publication Number Publication Date
DE69903961D1 true DE69903961D1 (de) 2002-12-19
DE69903961T2 DE69903961T2 (de) 2003-07-03

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69903961T Expired - Fee Related DE69903961T2 (de) 1998-08-18 1999-08-16 Muscarinagonisten und antagonisten

Country Status (30)

Country Link
US (5) US6093724A (de)
EP (1) EP1112272B1 (de)
JP (1) JP2002523416A (de)
KR (1) KR20010072784A (de)
CN (1) CN1312812A (de)
AR (1) AR020199A1 (de)
AT (1) ATE227724T1 (de)
AU (1) AU750566B2 (de)
BG (1) BG105256A (de)
BR (1) BR9913072A (de)
CA (1) CA2340946A1 (de)
CO (1) CO5130018A1 (de)
DE (1) DE69903961T2 (de)
EE (1) EE200100096A (de)
ES (1) ES2191455T3 (de)
HK (1) HK1038918A1 (de)
HU (1) HUP0103203A3 (de)
ID (1) ID27544A (de)
IL (1) IL141050A0 (de)
IS (1) IS5827A (de)
NO (1) NO20010804L (de)
NZ (1) NZ509762A (de)
PE (1) PE20000988A1 (de)
PL (1) PL346247A1 (de)
RU (1) RU2219179C2 (de)
SK (1) SK1892001A3 (de)
TR (1) TR200100462T2 (de)
WO (1) WO2000011001A1 (de)
YU (1) YU13301A (de)
ZA (1) ZA200100978B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292160A1 (en) * 2000-10-19 2002-04-29 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
JP5364878B2 (ja) * 2007-03-23 2013-12-11 アッヴィ・インコーポレイテッド アザアダマンタンのアセトアミドおよびカルボキサミド誘導体ならびにそれらの使用方法
CA2679876A1 (en) * 2007-03-23 2008-10-02 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
CA2765466A1 (en) * 2009-06-19 2010-12-23 Abbott Laboratories Diazahomoadamantane derivatives and methods of use thereof
WO2011011060A1 (en) 2009-07-22 2011-01-27 Puretech Ventures Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2560488B1 (de) 2010-04-23 2015-10-28 Cytokinetics, Inc. Bestimmte aminopyrimidine und aminotriazine, zusammensetzungen daraus und verfahren zu ihrer verwendung
NZ707955A (en) * 2010-09-23 2016-03-31 Abbvie Bahamas Ltd Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
US11325896B2 (en) 2017-12-20 2022-05-10 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
SG11202102349PA (en) 2018-09-28 2021-04-29 Karuna Therapeutics Inc Compositions and methods for treating disorders ameliorated by muscarnic receptor activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
EE03566B1 (et) * 1995-11-02 2001-12-17 Neurosearch A/S Kondenseerunud tropaanderivaadid, nende valmistamine ja kasutamine
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use

Also Published As

Publication number Publication date
CA2340946A1 (en) 2000-03-02
EP1112272B1 (de) 2002-11-13
PL346247A1 (en) 2002-01-28
WO2000011001A1 (en) 2000-03-02
HUP0103203A3 (en) 2002-10-28
NZ509762A (en) 2002-12-20
KR20010072784A (ko) 2001-07-31
BG105256A (en) 2001-11-30
US6323194B1 (en) 2001-11-27
US6251916B1 (en) 2001-06-26
EP1112272A1 (de) 2001-07-04
HUP0103203A2 (hu) 2002-01-28
YU13301A (sh) 2005-06-10
HK1038918A1 (zh) 2002-04-04
RU2219179C2 (ru) 2003-12-20
ID27544A (id) 2001-04-12
ZA200100978B (en) 2002-02-05
NO20010804D0 (no) 2001-02-16
SK1892001A3 (en) 2001-11-06
IL141050A0 (en) 2002-02-10
US6093724A (en) 2000-07-25
CO5130018A1 (es) 2002-02-27
DE69903961T2 (de) 2003-07-03
US20020045617A1 (en) 2002-04-18
ES2191455T3 (es) 2003-09-01
JP2002523416A (ja) 2002-07-30
ATE227724T1 (de) 2002-11-15
AR020199A1 (es) 2002-05-02
AU750566B2 (en) 2002-07-25
TR200100462T2 (tr) 2001-09-21
PE20000988A1 (es) 2000-09-30
CN1312812A (zh) 2001-09-12
EE200100096A (et) 2002-06-17
AU5775899A (en) 2000-03-14
NO20010804L (no) 2001-04-11
IS5827A (is) 2001-01-26
US6423842B1 (en) 2002-07-23
BR9913072A (pt) 2001-05-15
US6555550B1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
DE69913169D1 (de) Sportschuh und dafür vorgesehene dornen
DE69911378D1 (de) Fluorierte ionomere und verwendung davon
DE69932265D1 (de) Musikaktionsspielsystem und computerlesbare Aufzeichnungsvorrichtung
DE69924002D1 (de) Kompressions-abgestimmtes bragggitter und kompressions-abgestimmter laser
DE69921723D1 (de) USB-Vorrichtung und USB- Knotenpunktvorrichtung
DE69924155D1 (de) Fluoren-copolymere und daraus hergestellte vorrichtungen
DE69934881D1 (de) Selective il-2 agonisten und antagonisten
DE69823876D1 (de) Induktives bauelement und induktive bauelementanordnung
DE69738197D1 (de) Azolotriazine und pyrimidine
DE50112013D1 (de) Deodorantien und antiperspirantien
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
ID23076A (id) Popok sekali pakai
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
NO20005503D0 (no) Ny anvendelse
ATE227724T1 (de) Muscarinagonisten und antagonisten
ID26599A (id) Turunan triazola dan imidazola
DE69831750D1 (de) Biozide und biozide tücher
DE69904731T2 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
ID23083A (id) Popok sekali pakai
ID28852A (id) Bahan-bahan elektroluminesensi
DE59904577D1 (de) Metallocenkomplexe
DE69903143D1 (de) Chromanon und thiochromanon derivate

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee